
Metoliz G 1mg/500mg Tablet SR
Marketer
Crinova Healthcare
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Metoliz G 1mg/500mg Tablet SR
Glimepiride/Metformin 1mg/500mg Extended-Release Tablets are classified as antidiabetic agents. This dual-action medication manages type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to complications like kidney impairment, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks, juice) are vital for prevention. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before initiating treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring, along with potential blood tests to assess blood cell counts and liver function, are recommended by your doctor.
Uses of Metoliz G 1mg/500mg Tablet SR
Managing Type 2 diabetes
Major Benefits of Metoliz G 1mg/500mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; do not chew, crush, or fracture it. Take Metoliz G 1mg/500mg Extended-Release tablets with food.
Common Side effects of Metoliz G 1mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Metoliz G 1mg/500mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Metoliz G 1mg/500mg Extended-Release tablets with food.
How Metoliz G 1mg/500mg Tablet SR works:
Metoliz G SR tablets (1mg glimepiride/500mg metformin) combine two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts through a triple mechanism: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Metoliz G 1mg/500mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Metoliz G 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Extended-release Metoliz G tablets (1mg/500mg) are contraindicated during lactation due to the potential for infant harm from the medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.
KidneyCAUTION
Exercise caution when administering Metoliz G 1mg/500mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Metoliz G 1mg/500mg SR tablets are contraindicated in patients exhibiting severe kidney disease. Close monitoring of kidney function is recommended throughout the treatment period.
LiverCAUTION
Patients with liver impairment should use Metoliz G 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Medical advice is essential. For those with mild to moderate liver disease, initiation should be at a low dose; however, its use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Metoliz G 1mg/500mg Tablet SR :
Should you forget a Metoliz G 1mg/500mg SR tablet, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metoliz G 1mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
